Menu
GeneBe

AMMECR1

AMMECR nuclear protein 1, the group of Small nucleolar RNA protein coding host genes

Basic information

Region (hg38): X:110194185-110440318

Links

ENSG00000101935NCBI:9949OMIM:300195HGNC:467Uniprot:Q9Y4X0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis (Strong), mode of inheritance: XL
  • midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis (Moderate), mode of inheritance: XL
  • Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome (Supportive), mode of inheritance: XL

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosisXLHematologicEllipsocytosis requiring red blood cell transfusion has been described, and awareness may allow early diagnosis and managementAudiologic/Otolaryngologic; Craniofacial; Hematologic; Musculoskeletal; Renal27811305; 28089922

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AMMECR1 gene.

  • not provided (25 variants)
  • Inborn genetic diseases (9 variants)
  • Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis (5 variants)
  • AMMECR1-related condition (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AMMECR1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
2
clinvar
8
missense
17
clinvar
2
clinvar
19
nonsense
1
clinvar
3
clinvar
4
start loss
0
frameshift
1
clinvar
1
clinvar
2
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
0
non coding
1
clinvar
3
clinvar
4
Total 1 3 21 8 5

Variants in AMMECR1

This is a list of pathogenic ClinVar variants found in the AMMECR1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
X-110196698-AATGGATGCTGTGGATGAAGGAATACCAACAAACTTCTAAGAACTCTCATCAAAAACTAAAGCAATTTGCTTTGCCCCAGTGGCAGGCAGAAGGAATTTAGCCCATTATCTCACAAACTAGGAAAGGATTTTTGAATTCTGAACTAGCAGTCTGTCACTTGTCACAGTAACTATATGTATAAGCTGTATCATTTTGATATTCAGTGACTTTTTTGTAGTTTTAGAATATATATTCTGCAGCATACTTTAATTCATCACTTGATATGTTGGCTTCCTATTTGAAAAAATTATATATATTTTTCCAAAGACACACAGACACACACACATAACCATAAAATGAAGGTCATCTTCCTCCAGAATAATCTGTCATTTTTCCTGGGGATATATGTATGGACCTCCTATCGACATCAGTAAGTTATCTTTGTATGCATCATGGGAAGACTATACTTGCAGATGAGCTGGGCTCTAACTATAGCATATCTGAATGCCAACTCCATTTTCACAGGTGTGACATAACATCTTATCAATGTAGTAAATGTGTTTCTATCAAAAGTATGTAGTGCAGAAAGAAATTCAAGCTATTTTATAGTATCTCTAAAACTCTAATATTGTCCCCATGACAAACATATCTGAAATCATGGCAAATATGAACTTTTGTTTTACTAAATTATCTTTACCATATCTTTAGATGGTAGCTAAAATGGATTCTAGCCAATCATGACTTATTGAAACCTAGAGCTAACAAATTTAAATTAATATAAAATAGACAAATGTCTCTTATTGGTTATTTGCTCAAAATAATTTTTTTTCAGCTTAAAAAAATACTTAAGAGTAAGGAATTTGTCTAATCTTCTGTTTCACATATAGAAACAATAAAGTTTTACAAGAATATTTTTCTAAATTGCCTTTTTTCTAACCCCTCTTAATTCCACTTAATTATATTCTTCTCAAAGGCACTAAATTCTGTATCTGCTCTCTTCCTAATATTTGCTGCTCATAAAATGTTTCCTGTAGCCTTTTTGAAAGGTAGTTTGTACCTTCTCCAAACAGTGTTTTAGTTTGCAAATTGGTTCTATAAAGTGGTGAGGCAGTCTCTTCTATGATAACCAGCACAATAGGGATAAATGATTTCTCTCTCTCTGTGACAAGCCCTATCACGGACCTTTGAATGCTCACTACTAGAACTAAAGTTCATGTATTTTCACCATGGGAAAAACATATACTTAAGGAGTGAAGACCCAACTACTAGGCTGTCATAGCAAAGTGAATTTCAGACAAAAATCAAGAGTAATATACAAATACCTGAATTTGATATGAATTAATCCCAAACTCAGGTATCAAAAAACAACTATCTTACTGAGGAAAACTAAAGACGAACCTAAGTAAAATCCCTAAAAACTGCACACTTTCTTCCATCCACAGTCAAAGGAAGGGAGGCAGGGAAGGAAGAAGGAAAACGGGAAGGAAGAAGGAAAACAGGAAGCAAAACGGGAAGAAAGGCAAGGAGGACAGAAAAACAGAAACCTGACTGAGACAGCAAAGCAAAATTCTACATAATATTATAAGGAAAAAAAAACCCAAAATTATATATGCTGCAAAAAAAAAATCAACGATCTAAAATAATAAAACAGGATCTTAACAAATGCCATTTTTCTACCCGTTACCATGATGATCTTAGTTGACGATGTCGAAGCTTCACCATGGCAACGGAAACTATCATCATAAAATGGTACAGTAAAAGAGATAGCTAGACCAAGAAGGTGTAGGGTCTCCTGGGAAGAGGTCTGCAGAGAGGCCCAGTGACTGGTTGTGCGGCTCAGTGTCAGGAATAATGGTTGTATGGCGGAAGGGGATGCCCAATGCCATTTTGGAAATGATGATGCTGGCGATGAGCAAGGTATTCAGCATAGCTCAGGGTCATCTTTTCACTACGATACCTGAAAGAAAGTCAGGGAAGAGAAAAGTTAACATTGAGAAGTAGGTGACATGCCATTGTCACTGCTAGGAAGGACCTTAAAGATAATTTTATAGATCAGGAAACGGGGTCCCAGAGAGAAGCAGTGACTGCCCAAGGTCACAGAGATAGTAAGTAGCAAAGCTAAGATCAGAACTTGGAAATCAAAAGTCTGAGTCCAGTGCTCTTTGCACTCTACTACTCCTTGTTTAAATTGTTCTTTTAAAAATTTTATTGTCCCCTCAGCCCCAGTTTTCTAACAGGAGTATGCATCTCATTCGATTCAGTTGATTATTTTTCTTCAGAAATCTTCCACCTCTCCCTCTTTTACTGTTCCTTTCTCTGTCCACACATCTACTTAGGTCTTACCATTAAGTAACAACAACAAAAACAACTTTTCTTAATTCTGGTATCCTGAACTCTCACTTTTCCCCATGTCTGGCTTTCTTTTCATTGCCACATTTCTCAAATAGTTGTGTGTATTTTCTGCCTTCAATCCCCATCTCACACTACTACTCAGCTCAGTGCTCCTTGGCTTCTGCTGCCACCCTTCCATGGAAATAGCCATCAGAAGGCTTCCCCTGACTCAGCTT-A Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis Likely pathogenic (May 02, 2023)3066002
X-110198517-G-T Uncertain significance (Dec 01, 2022)2661189
X-110198562-A-G Benign (Dec 31, 2019)779292
X-110198565-T-C Likely benign (Mar 01, 2023)2661190
X-110198591-C-T not specified Uncertain significance (Oct 04, 2022)3116027
X-110198624-C-A Uncertain significance (May 20, 2022)1801042
X-110200910-C-A Benign (May 20, 2021)1285799
X-110200911-A-T Benign (May 20, 2021)1287673
X-110200952-A-T Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis Likely pathogenic (Aug 17, 2023)2582539
X-110200980-T-C Likely benign (Jul 31, 2018)763992
X-110201019-T-C Likely benign (Oct 24, 2018)721778
X-110201036-G-A Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis Likely pathogenic (May 31, 2019)998005
X-110201042-G-A Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis Uncertain significance (Nov 20, 2020)1678616
X-110201047-C-T Likely pathogenic (Mar 20, 2020)1254296
X-110201050-C-A Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis Uncertain significance (Mar 24, 2021)1678555
X-110202286-G-A Benign (May 20, 2021)1263366
X-110202479-C-T Uncertain significance (Oct 26, 2022)2500484
X-110202486-T-C Benign (May 14, 2018)746580
X-110264538-AAGTACCT-GATTAC Uncertain significance (Aug 01, 2023)2579102
X-110264543-C-T Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis Pathogenic (May 17, 2017)375304
X-110264547-T-C Uncertain significance (Jun 26, 2020)1312746
X-110264571-G-A Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis Uncertain significance (Apr 02, 2021)375305
X-110317617-CG-C Short stature Pathogenic (Nov 18, 2001)599546
X-110317617-C-CG Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis Pathogenic (Jul 11, 2023)817076
X-110317623-GTCCGGGGCTGCTGGTA-G Likely pathogenic (Jul 13, 2018)817146

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AMMECR1protein_codingprotein_codingENST00000262844 6246048
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.8210.17800000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.08901240.7270.000009182095
Missense in Polyphen1945.2260.42011736
Synonymous0.2734749.40.9510.00000353710
Loss of Function2.64110.00.09956.96e-7187

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Disease
DISEASE: Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis (MFHIEN) [MIM:300990]: An X-linked recessive disorder with onset in early childhood, characterized by midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis. Variable clinical features include anemia, and mild early motor or speech delay. {ECO:0000269|PubMed:27811305, ECO:0000269|PubMed:28089922}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Alport syndrome with mental retardation, midface hypoplasia and elliptocytosis (ATS-MR) [MIM:300194]: A X-linked contiguous gene deletion syndrome characterized by glomerulonephritis, sensorineural hearing loss, mental retardation, midface hypoplasia and elliptocytosis. {ECO:0000269|PubMed:10049589}. Note=The gene represented in this entry may be involved in disease pathogenesis.;

Recessive Scores

pRec
0.338

Intolerance Scores

loftool
0.0853
rvis_EVS
-0.1
rvis_percentile_EVS
46.2

Haploinsufficiency Scores

pHI
0.896
hipred
Y
hipred_score
0.662
ghis
0.652

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ammecr1
Phenotype

Zebrafish Information Network

Gene name
ammecr1
Affected structure
post-vent region
Phenotype tag
abnormal
Phenotype quality
kinked

Gene ontology

Biological process
biological_process
Cellular component
nucleus
Molecular function
protein binding